Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3456

Diabetic Eye Disease Devices Market by Devices (Surgery, Ophthalmic Diagnostic & Monitoring Equipment, and Vision Care), by Diseases (Diabetic Retinopathy, Diabetic Macular Edema (DME), Cataract, Glaucoma and Others), and End-Users (Hospitals, Ophthalmic Clinics, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

LI_183992
Pages: NA
Jul 2018 | 572 Views
face gplus_n
Author's : NA
Tables: NA
Charts: NA
twit_n pr_n

Diabetic eye disease devices are medical devices used to treat and diagnose renal complications that occur due to diabetes. The most common diabetic eye diseases include diabetic retinopathy, diabetic macular edema, cataract, and glaucoma. These conditions may lead to complete blindness if not treated on time.

The growing prevalence of diabetic eye diseases owning to increasing smoking addiction, eye injury, hormone replacement therapy, and diseases such as diabetes, hypertension, and obesity drive the diabetic eye disease devices market growth. In addition, increasing geriatric population who suffer from diabetic eye diseases increases the market growth.

There is an increasing demand for diabetic eye diseases devices to avoid visual impairment and loss of vision. However, dearth of skilled professionals with expertise in ophthalmic surgery, lack of healthcare infrastructure in developing countries, low awareness of eye surgery, and stringent government regulations associated with the safety & efficacy of medical devices hamper the market growth. Ongoing R&D activities related to diabetic eye disease devices are anticipated to present new opportunities for the market.

The market is segmented on the basis of devices, diseases, end-users, and region. Based on devices, the market is divided into surgery, ophthalmic diagnostic & monitoring equipment, and vision care. Based on diseases the market is categorized into diabetic retinopathy, diabetic macular edema (DME), cataract, glaucoma, and others. Based on end-users the market is segmented into hospitals, ophthalmic clinics, and others. Based on region, the global diabetic eye disease devices market is segmented into North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits:

  • The study provides an in-depth analysis of the global diabetic eye disease devices market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities from 20172023 in terms of value.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

Diabetic Eye Disease Devices Market Key Segment:

By Devices

  • Surgery
    • Cataract Surgery Devices
      • Intra Ocular Lens (IOL)
        • Monofocal
        • Multifocal
        • Toric
        • Accomodating
      • Ophthalmic Viscoelastic Devices (OVD)
        • Cohesive
        • Dispersive
      • Phacoemulsification Devices
    • Glaucoma Surgery Devices
      • Glaucoma Drainage Devices
      • Glaucoma Lasers
      • Stents and Implants
      • Systems
    • Refractive Surgery Devices
    • Microkeratome
    • Vitreo Retinal Surgery Devices
      • Vitrectomy Machines
      • Photocoagulation Lasers
    • Ophthalmic Lasers
      • Excimer Laser
      • Femtosecond Laser
      • YAG Laser
      • Glaucoma Lasers
      • Photocoagulation Lasers
  • Ophthalmic Diagnostic & Monitoring Equipment
    • Optical Coherence Tomographers (OCT Scanners)
    • Fundus Cameras
      • Non-Mydriatic
      • Mydriatic
      • Others
    • Slit Lamps
    • Visual Field Analyzers/Perimeters
    • Wavefront Aberrometers
    • Ophthalmic Ultrasound Imaging Systems
    • Ophthalmoscopes
    • Tonometers
    • Autorefractors/Phoropters
    • Keratometers
    • Corneal Topographers
    • Retinoscope
    • Pachymeter
    • Specular Microscope
    • Biometers
    • Optotype Projectors
    • Dioptometers
  • Vision Care
    • Contact Lens
    • Spectacles

By Disease

  • Diabetic Retinopathy
  • Diabetic Macular Edema (DME)
  • Cataract
  • Glaucoma
  • Others

By End-User

  • Hospitals
  • Ophthalmic Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • The Middle East
    • Africa

List of players profiled in the report

  • Novartis AG
  • Johnson & Johnson
  • Aaren Scientific Inc.
  • Valeant Pharmaceuticals International, Inc.
  • Essilor International S.A.
  • Alcon Inc.
  • Nidek Co., Ltd.
  • STAAR Surgical Company
  • Actavis plc
  • CooperVision AG
 

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 DIABETIC EYE DISEASE DEVICES MARKET, BY DEVICES

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. SURGERY

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.2.4. Cataract Surgery Devices

4.2.4.1. Market size and forecast
4.2.4.2. IntraOcular Lens (IOL)

4.2.4.2.1. Market size and forecast
4.2.4.2.2. Monofocal

4.2.4.2.2.1.Market size and forecast

4.2.4.2.3. Multifocal

4.2.4.2.3.1.Market size and forecast

4.2.4.2.4. Toric

4.2.4.2.4.1.Market size and forecast

4.2.4.2.5. Accomodating

4.2.4.2.5.1.Market size and forecast

4.2.4.3. Ophthalmic Viscoelastic Devices (OVD)

4.2.4.3.1. Market size and forecast
4.2.4.3.2. Cohesive

4.2.4.3.2.1.Market size and forecast

4.2.4.3.3. Dispersive

4.2.4.3.3.1.Market size and forecast

4.2.4.4. Phacoemulsification Devices

4.2.4.4.1. Market size and forecast

4.2.5. Glaucoma Surgery Devices

4.2.5.1. Market size and forecast
4.2.5.2. Glaucoma Drainage Devices

4.2.5.2.1. Market size and forecast

4.2.5.3. Glaucoma Lasers

4.2.5.3.1. Market size and forecast

4.2.5.4. Stents and Implants

4.2.5.4.1. Market size and forecast

4.2.5.5. Systems

4.2.5.5.1. Market size and forecast

4.2.6. Refractive Surgery Devices

4.2.6.1. Market size and forecast

4.2.7. Microkeratome

4.2.7.1. Market size and forecast

4.2.8. Vitreo Retinal Surgery Devices

4.2.8.1. Market size and forecast
4.2.8.2. Vitrectomy Machines

4.2.8.2.1. Market size and forecast

4.2.8.3. Photocoagulation Lasers

4.2.8.3.1. Market size and forecast

4.2.9. Ophthalmic Lasers

4.2.9.1. Market size and forecast
4.2.9.2. Excimer Laser

4.2.9.2.1. Market size and forecast

4.2.9.3. Femtosecond Laser

4.2.9.3.1. Market size and forecast

4.2.9.4. YAG Laser

4.2.9.4.1. Market size and forecast

4.2.9.5. Glaucoma Lasers

4.2.9.5.1. Market size and forecast

4.2.9.6 Photocoagulation Lasers

4.2.9.6.1. Market size and forecast

4.3. OPHTHALMIC DIAGNOSTIC & MONITORING EQUIPMENT

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.3.4. Optical Coherence Tomographers (OCT Scanners)

4.3.4.1. Market size and forecast

4.3.5. Fundus Cameras

4.3.5.1. Market size and forecast
4.3.5.2 Non-Mydriatic

4.3.5.2.1. Market size and forecast

4.3.5.3. Mydriatic

4.3.5.3.1. Market size and forecast

4.3.5.4. Others

4.3.5.4.1. Market size and forecast

4.3.6. Slit Lamps

4.3.6.1. Market size and forecast

4.3.7. Visual Field Analyzers/Perimeters

4.3.7.1. Market size and forecast

4.3.8. Wavefront Aberrometers

4.3.8.1. Market size and forecast

4.3.9. Ophthalmic Ultrasound Imaging Systems

4.3.9.1. Market size and forecast

4.3.10. Ophthalmoscopes

4.3.10.1. Market size and forecast

4.3.11. Tonometers

4.3.11.1. Market size and forecast

4.3.12. Autorefractors/Phoropters

4.3.12.1. Market size and forecast

4.3.13. Keratometers

4.3.13.1. Market size and forecast

4.3.14. Corneal Topographers

4.3.14.1. Market size and forecast

4.3.15. Retinoscope

4.3.15.1. Market size and forecast

4.3.16. Pachymeter

4.3.16.1. Market size and forecast

4.3.17. Specular Microscope

4.3.17.1. Market size and forecast

4.3.18. Biometers

4.3.18.1. Market size and forecast

4.3.19. Optotype Projectors

4.3.19.1. Market size and forecast

4.3.20. Dioptometers

4.3.20.1. Market size and forecast

4.4. VISION CARE

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.4.4. Contact Lens

4.4.4.1. Market size and forecast

4.4.5 Spectacles

4.4.5.1. Market size and forecast

Chapter: 5 DIABETIC EYE DISEASE DEVICES MARKET, BY DISEASE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. DIABETIC RETINOPATHY

5.2.1. Market size and forecast

5.3. DIABETIC MACULAR EDEMA (DME)

5.3.1. Market size and forecast

5.4. CATARACT

5.4.1. Market size and forecast

5.5. GLAUCOMA

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 DIABETIC EYE DISEASE DEVICES MARKET, BY END-USER

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITALS

6.2.1. Market size and forecast

6.3. OPHTHALMIC CLINICS

6.3.1. Market size and forecast

6.4. OTHERS

6.4.1. Market size and forecast

Chapter: 7 DIABETIC EYE DISEASE DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Diabetic Eye Disease Devices Market by Devices
7.2.5. North America Diabetic Eye Disease Devices Market by Disease
7.2.6. North America Diabetic Eye Disease Devices Market by End-User

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Diabetic Eye Disease Devices Market by Devices
7.3.5. Europe Diabetic Eye Disease Devices Market by Disease
7.3.6. Europe Diabetic Eye Disease Devices Market by End-User

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. India market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Diabetic Eye Disease Devices Market by Devices
7.4.5. Asia-Pacific Diabetic Eye Disease Devices Market by Disease
7.4.6. Asia-Pacific Diabetic Eye Disease Devices Market by End-User

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Latin America market size and forecast
7.5.3.2. Middle East market size and forecast
7.5.3.3. Africa market size and forecast

7.5.4. LAMEA Diabetic Eye Disease Devices Market by Devices
7.5.5. LAMEA Diabetic Eye Disease Devices Market by Disease
7.5.6. LAMEA Diabetic Eye Disease Devices Market by End-User

Chapter: 8 COMPANY PROFILES

8.1. NOVARTIS AG.

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. JOHNSON & JOHNSON

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. AAREN SCIENTIFIC INC.

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. ESSILOR INTERNATIONAL S.A.

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. ALCON INC.

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. NIDEK CO., LTD.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. STAAR SURGICAL COMPANY

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. ACTAVIS PLC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. COOPERVISION AG

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry

Request sample

OR

Purchase Full Report of
Diabetic Eye Disease Devices Market- Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Online Only
  • $3456
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370
  • Restricted to one authorized users
  • One print only
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8995
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo